Association between proteomic profile and molecular response in chronic myeloid leukemia patients

Leuk Lymphoma. 2018 Apr;59(4):1016-1018. doi: 10.1080/10428194.2017.1344841. Epub 2017 Jul 11.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Computational Biology
  • Female
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Male
  • Mass Spectrometry
  • Middle Aged
  • Pilot Projects
  • Protein Kinase Inhibitors / therapeutic use*
  • Proteome / analysis*
  • Proteomics
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Protein Kinase Inhibitors
  • Proteome